Abstract:Background: Gliomas, known for their complex and aggressive characteristics, are deeply influenced by the tumor microenvironment. Matrix metalloproteinases (MMPs) play a vital role in shaping this environment, presenting an opportunity for novel treatment strategies. Methods: We collected six bulk RNA datasets, one single-cell RNA sequencing (scRNA-seq) dataset, and gene sets related to Matrix Metalloproteinases (MMPs), Endothelial-Mesenchymal Transformation (EndMT), and sprouting angiogenesis. We computed enrichment scores using Gene Set Variation Analysis (GSVA) and Single-sample Gene Set Enrichment Analysis (ssGSEA). To analyze immune infiltration, we employed the CIBERSORT method. Data analysis techniques included the log-rank test, Cox regression, Kruskal-Wallis test, and Pearson correlation. For single-cell data, we utilized tools such as Seurat and CellChat for dimensionality reduction, clustering, and cell communication analysis. Results: 1. MMP14 was identified as an independent prognostic marker, highly expressed in myeloid cells in recurrent glioblastoma, highlighting these cells as functionally significant. 2. C-C Motif Chemokine Ligand (CCL) signaling from MMP14+ myeloid cells was identified as a critical immune regulatory pathway, with high C-C Motif Chemokine Receptor 1 (CCR1) expression correlating with increased M2 macrophage infiltration and PD-L1 expression. 3. Patients with high MMP14 expression showed better responses to bevacizumab combined chemotherapy. 4. Signaling pathways involving Visfatin, VEGF, and TGFb, emanating from myeloid cells, significantly impact endothelial cells. These pathways facilitate EndMT and angiogenesis in gliomas. 5. Nicotinamide Phosphoribosyltransferase (NAMPT) showed a strong link with angiogenesis and EndMT, and its association with chemotherapy resistance and differential sensitivity to bevacizumab was evident. Conclusions: MMP14+ myeloid cells are critical in promoting tumor angiogenesis via EndMT and in mediating immunosuppression through CCL signaling in glioblastoma. MMP14 and NAMPT serve as vital clinical indicators for selecting treatment regimens in recurrent glioma. The study suggests that a combined blockade of CCR1 and CD274 could be a promising therapeutic strategy.

Distribution of CXCL12 and CXC chemokine receptor-4 in glioblastoma microenviroment and the role of them in invasion and migration

The Role of SDF-1/CXCR4 Axis in Proliferation,Migration and Invasion of Malignant Glioma Cell Lines

Bioinformatics analysis of MMP14+ myeloid cells affecting endothelial-mesenchymal transformation and immune microenvironment in glioma

The Chemokine Cxcl12 and Its Receptor Cxcr4 Promote Glioma Stem Cell-Mediated Vegf Production and Tumour Angiogenesis Via Pi3k/Akt Signalling

Prognostic Value and Therapeutic Perspectives of CXCR Members in the Glioma Microenvironment

Upregulation of Chemokine Receptor Ccr10 is Essential for Glioma Proliferation, Invasion and Patient Survival

Bioinformatic Analyses Reveal the Key Pathways and Genes in the CXCR4 Mediated Mesenchymal Subtype of Glioblastoma

Down-regulation of CXCR4 expression inhibits invasion and VEGF production of glioma stem cells

Activation of Chemokine Receptor CXCR4 Promoted Glioma Stem Cells Migration and Its Mechanism.

Chemokine Receptor CXCR4 Interacts with Nuclear Receptor Nur77 and Promote Glioma Invasion and Progression.

Human Astrocytes Secrete Il-6 to Promote Glioma Migration and Invasion Through Upregulation of Cytomembrane Mmp14

CXCL5 promotes the proliferation and migration of glioma cells in autocrine- and paracrine-dependent manners.

Development and Validation of CXCR4 Nomogram-Based Immune Infiltration/Tumor Inflammation in Primary Glioblastoma

Prognostic marker CXCL5 in glioblastoma polyformis and its mechanism of immune invasion

The CXCL Family Contributes to Immunosuppressive Microenvironment in Gliomas and Assists in Gliomas Chemotherapy

Predictive value of expression of the CXCR4/Akt signaling pathway in the peripheral blood for brain glioma

OS10.7.A Activation of the CCR8-ACP5 axis by human microglia/macrophage derived CCL18 promotes glioma growth

CXCR4-STAT3 Axis Plays a Role in Tumor Cell Infiltration in an Orthotopic Mouse Glioblastoma Model

ITGB4 upregulation is associated with progression of lower grade glioma

The expression of matrix metalloproteinase-2 and-9 in human gliomas of different pathological grades

Research on the correlativity of expressions of CXCL12 and CXCR4 with the invasiveness and recurrence of adamantimous craniopharyngiomas